Adrian M. Guerrero

Adrian M. Guerrero

Auto-generated profile, based on publicly available information

Adrian M. Guerrero

Department of Chemistry, The Scripps Research Institute

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2019 in ACS Pharmacology & Translational Science
Verified
Journal Article
Open access
ABAlessandro Bonifazi
Alessandro Bonifazi
HYHideaki Yano
Hideaki Yano
AGAdrian M. Guerrero
Adrian M. Guerrero
VKVivek Kumar
Vivek Kumar
AHAlexander F. Hoffman
Alexander F. Hoffman
ANAmy Hauck Newman
Amy Hauck Newman
The discovery of functionally biased and physiologically beneficial ligands directed toward G-protein coupled receptors (GPCRs) has provided the impetus to design dopamine D2 receptor (D2R) targeted molecules that may be therapeutically advantageous for the treatment of certain neuropsychiatric or basal ganglia related disorders. Here we describe the synthesis of a novel series of D2R agonists linking the D2R unbiased agonist sumanirole with privileged secondary molecular fragments. The resulting ligands demonstrate improved D2R affinity and selectivity over sumanirole. Extensive in vitro functional studies and bias factor analysis led to the identification of a novel class of highly potent Go-protein biased full D2R agonists with more than 10-fold and 1,000-fold bias selectivity toward activation of specific G-protein subtypes and β-arrestin, respectively. Intracellular electrophysiological recordings from midbrain dopamine neurons demonstrated that Go-protein selective agonists can elicit prolonged ligand-induced GIRK activity via D2Rs, which may be beneficial in the treatment of dyskinesias associated with dopamine system dysfunction.

16 March 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ABAlessandro Bonifazi
Alessandro Bonifazi
HYHideaki Yano
Hideaki Yano
MEMichael P. Ellenberger
Michael P. Ellenberger
LMLudovic Muller
Ludovic Muller
VKVivek Kumar
Vivek Kumar
ANAmy Hauck Newman
Amy Hauck Newman

19 June 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FBFrancisco O. Battiti
Francisco O. Battiti
SCSophie L. Cemaj
Sophie L. Cemaj
AGAdrian M. Guerrero
Adrian M. Guerrero
ASAnver Basha Shaik
Anver Basha Shaik
JLJenny Lam
Jenny Lam
ABAlessandro Bonifazi
Alessandro Bonifazi

12 August 2016 in ACS Combinatorial Science
Verified
Journal Article
Open access
SHSina Haftchenary
Sina Haftchenary
SNShawn D. Nelson
Shawn D. Nelson
LFLaura Furst
Laura Furst
SDSivaraman Dandapani
Sivaraman Dandapani
SFSteven J. Ferrara
Steven J. Ferrara
APAndrew J. Phillips
Andrew J. Phillips
Efficient syntheses of chiral fragments derived from chiral amino alcohols are described. Several unique scaffolds were readily accessed in 1–5 synthetic steps leading to 45 chiral fragments, including oxazolidinones, morpholinones, lactams, and sultams. These fragments have molecular weights ranging from 100 to 255 Da and are soluble in water (0.085 to >15 mM).

1 July 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DBDebasish Bandyopadhyay
Debasish Bandyopadhyay
Gildardo RiveraGildardo Rivera
Gildardo Rivera
JSJorge L. Sanchez
Jorge L. Sanchez
JRJesse Rivera
Jesse Rivera
JGJose C. Granados
Jose C. Granados
BBBimal K. Banik
Bimal K. Banik

1 January 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DBDebasish Bandyopadhyay
Debasish Bandyopadhyay
JSJorge L. Sanchez
Jorge L. Sanchez
AGAdrian M. Guerrero
Adrian M. Guerrero
FCFang-Mei Chang
Fang-Mei Chang
JGJose C. Granados
Jose C. Granados
BBBimal Banik
Bimal Banik